InsidersTradesSigma
Follow the SynAct Pharma AB share price and the full directors' dealings record of the company, a publicly traded company based in Finland. Shares are listed on the FI market, under the authority of FIN-FSA. Operating in the Health Care sector, SynAct Pharma AB has logged 9 public disclosures. Market capitalisation: €974.4m. The latest transaction was disclosed on 9 March 2026 (Purchase). Among the most active insiders: Thomas Jonassen. The full history is openly available.
9
Insider Decl.
n/a
Thresholds
€26,965
4 ops.
Buy Volume
€75,074
1 ops.
Sell Volume
Analyst consensus: bullish or bearish?
Analysts rate SynAct Pharma AB Strong Buy (bullish), based on 2 analysts. Average price target: SEK 35.00.
35Σ signal
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.
AI analysis generation is paused.
Last declaration on 9 March 2026
Declarations9 total
7,900 shares@ €1.68490.0017% mcap100.0% of flowAktieISIN SE0008241491FI:A003W854-1
1,500 shares@ €1.6780.0003% mcap100.0% of flowAktieISIN SE0008241491FI:A003W835-1
2,700 shares@ €1.67050.0006% mcap100.0% of flowAktieISIN SE0008241491FI:A003W815-1
3,529 shares@ €1.87780.0008% mcap100.0% of flowAktieISIN SE0008241491FI:A003V108-1
15,275 shares@ SEK 49.6507100.0% of flowAktieISIN SE0008241491FI:A001Q764-1
1,456,263 shares0AktieISIN SE0008241491FI:A001P435-2
2,296,651 shares0AktieISIN SE0008241491FI:A001P434-1
1,456,263 shares0AktieISIN SE0008241491FI:A001P432-1
2,296,651 shares0AktieISIN SE0008241491FI:A001P431-1
9 of 9 declarations
About SynAct Pharma AB
SynAct Pharma AB is a biopharmaceutical company focused on developing treatments for inflammatory and autoimmune diseases. It is listed on the Stockholm Stock Exchange (XSTO).